Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2015, Article ID 351015, 5 pages
http://dx.doi.org/10.1155/2015/351015
Research Article

Analysis of Serum MicroRNAs as Potential Biomarker in Coronary Bifurcation Lesion

Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Changle Road No. 68, Nanjing, Jiangsu 210029, China

Received 31 October 2014; Revised 11 January 2015; Accepted 17 February 2015

Academic Editor: Varodom Charoensawan

Copyright © 2015 Yan Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Lian, J. Guo, Z. Chen et al., “Positive association between GCKR rs780093 polymorphism and coronary heart disease in the aged Han Chinese,” Disease Markers, vol. 35, no. 6, pp. 863–868, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Wu, R.-X. Yin, Q.-Z. Lin et al., “Two polymorphisms in the Fractalkine receptor CX3CR1 gene influence the development of atherosclerosis: a meta-analysis,” Disease Markers, vol. 2014, Article ID 913678, 13 pages, 2014. View at Publisher · View at Google Scholar
  3. C. Frangos, S. Noble, N. Piazza et al., “Impact of bifurcation lesions on angiographic characteristics and procedural success in primary percutaneous coronary intervention for ST-segment elevation myocardial infarction,” Archives of Cardiovascular Diseases, vol. 104, no. 4, pp. 234–241, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. X. Zhou, P. Yuan, and Y. He, “Role of microRNAs in peripheral artery disease (review),” Molecular Medicine Reports, vol. 6, no. 4, pp. 695–700, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. A. S. M. Sayed, K. Xia, T. L. Yang, and J. Peng, “Circulating microRNAs: a potential role in diagnosis and prognosis of acute myocardial infarction,” Disease Markers, vol. 35, no. 5, pp. 561–566, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. S. de Rosa, A. Curcio, and C. Indolfi, “Emerging role of micrornas in cardiovascular diseases,” Circulation Journal, vol. 78, no. 3, pp. 567–575, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Sianos, M. A. Morel, A. P. Kappetein et al., “The SYNTAX score: an angiographic tool grading the complexity of coronary artery disease,” EuroIntervention, vol. 1, pp. 219–227, 2005. View at Google Scholar
  8. M. B. Eisen, P. T. Spellman, P. O. Brown, and D. Botstein, “Cluster analysis and display of genome-wide expression patterns,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 25, pp. 14863–14868, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. D. Siu, “A new way of targeting to treat coronary artery disease,” Journal of Cardiovascular Medicine, vol. 11, no. 1, pp. 1–6, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. V. Portnoy, V. Huang, R. F. Place, and L.-C. Li, “Small RNA and transcriptional upregulation,” Wiley Interdisciplinary Reviews: RNA, vol. 2, no. 5, pp. 748–760, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Gal-Ben-Ari, J. W. Kenney, H. Ounalla-Saad et al., “Consolidation and translation regulation,” Learning and Memory, vol. 19, no. 9, pp. 410–422, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. J. M. Lorenzen, F. Martino, and T. Thum, “Epigenetic modifications in cardiovascular disease,” Basic Research in Cardiology, vol. 107, no. 2, article 245, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Fichtlscherer, A. M. Zeiher, and S. Dimmeler, “Circulating microRNAs: biomarkers or mediators of cardiovascular diseases?” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 11, pp. 2383–2390, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Hoekstra, C. A. C. van der Lans, B. Halvorsen et al., “The peripheral blood mononuclear cell microRNA signature of coronary artery disease,” Biochemical and Biophysical Research Communications, vol. 394, no. 3, pp. 792–797, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. X. Li, N. Du, Q. Zhang et al., “MicroRNA-30d regulates cardiomyocyte pyroptosis by directly targeting foxo3a in diabetic cardiomyopathy,” Cell Death and Disease, vol. 5, no. 10, Article ID e1479, 2014. View at Publisher · View at Google Scholar
  16. T. Staszel, B. Zapała, A. Polus et al., “Role of microRNAs in endothelial cell pathophysiology,” Polskie Archiwum Medycyny Wewnetrznej, vol. 121, no. 10, pp. 361–367, 2011. View at Google Scholar · View at Scopus
  17. N. Takeshita, I. Hoshino, M. Mori et al., “Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma,” British Journal of Cancer, vol. 108, no. 3, pp. 644–652, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. B. Zhang, J. Chen, Z. Ren et al., “A specific miRNA signature promotes radioresistance of human cervical cancer cells,” Cancer Cell International, vol. 13, no. 1, article 118, 2013. View at Publisher · View at Google Scholar · View at Scopus